“Because the dose of the drug is increased at regular ... Novo Nordisk (NVO) markets both Saxenda, also known as liraglutide, ...

In the new SCALE Kids study, which has been published in the New England Journal of Medicine, a daily 3mg dose of Saxenda reduced the body mass index (BMI) of the children by an average of 5.8% ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Saxenda is approved by the FDA for chronic weight ... you must lose at least 5 per cent of your body weight after 12 weeks on the full dose in order to continue with the medication.

depending on the dosage, before discounts or insurance, according to Novo Nordisk, which also sells a version of liraglutide approved for obesity, called Saxenda. “There are many people on this ...